Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes.

Dri, Diego Alejandro; Rinaldi, Federica; Carafa, Maria; Marianecci, Carlotta

Dri, Diego Alejandro; Rinaldi, Federica; Carafa, Maria; Marianecci, Carlotta.

Afiliação

Dri DA; Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185, Rome, Italy. diegoalejandro.dri@uniroma1.it.
Rinaldi F; Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185, Rome, Italy.
Carafa M; Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185, Rome, Italy.
Marianecci C; Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185, Rome, Italy.

Drug Deliv Transl Res ; 13(3): 757-769, 2023 03.

Article em En | MEDLINE | ID: mdl-36450964

Assuntos

Nanomedicina; Nanoestruturas; Nanotecnologia

Palavras-chave

Characterization; Clinical trials; Critical quality attributes; Nanocarriers; Nanomedicines; Regulatory

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanoestruturas / Nanomedicina Tipo de estudo: Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google